Maybe 0.5-1 mg per week, then ramp up
In addition to causing your pancreas to release insulin, semaglutide also blocks a hormone that causes your liver to release sugar (glucagon)
The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings
Some plans classify GLP-1s as preferred, non-preferred, or excluded drugs
Clinical trials have shown that retatrutide, a triple-agonist targeting GLP-1, GIP, and glucagon receptors, offers powerful metabolic benefits, but like all medications, it comes with a defined safety profile